Prevalence and antifungal susceptibility of Cryptococcus neoformans isolated from pigeon excreta in Chon Buri Province, Eastern Thailand

Medical Mycology Journal

Volumn 54, Issue 3, 2013, Pages 303-307

  Tangwattanachuleeporn, Marut ^a,b   Somparn, Poorichaya ^c   Poolpol, Kulwara ^a   Gross, Uwe ^b   Weig, Michael ^b   Bader, Oliver ^b  

^a BURAPHA UNIVERSITY   (Thailand)

^b UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^c CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Antifungal drug susceptibility; Cryptococcus neoformans; Pigeon excreta; Thailand

Indexed keywords

AMPHOTERICIN B; FLUCONAZOLE; ITRACONAZOLE;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; FUNGAL STRAIN; FUNGUS ISOLATION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PIGEON; PREVALENCE; SEROTYPE; STRAIN DIFFERENCE; THAILAND;

ANIMALS; ANTIFUNGAL AGENTS; COLUMBIDAE; CRYPTOCOCCUS NEOFORMANS; DRUG RESISTANCE, MICROBIAL; FECES; THAILAND;

EID: 84883390353     PISSN: 21856486     EISSN: 2186165X     Source Type: Journal    
DOI: 10.3314/mmj.54.303     Document Type: Article

References (23)

1. Probst C, Pongratz G, Capellino S, Szeimies RM, Scholmerich J, Fleck M, Salzberger B, and Ehrenstein B: Cryptococcosis mimicking cutaneous cellulitis in a patient suffering from rheumatoid arthritis: a case report. BMCInfect Dis 10: 239, 2010.
2. Jongwutiwes U, Sungkanuparph S, and Kiertiburanakul S: Comparison of clinical features and survival between cryptococcosis in human immunodeficiency virus HIV-positive and HIV-negative patients. Jpn J Infect Dis 61(2): 111-115, 2008.
3. Girish Kumar CP, Prabu D, Mitani H, Mikami Y, and Menon T: Environmental isolation of Cryptococ-cus neoformans and Cryptococcus gattii from living trees in Guindy National Park, Chennai, South India. Mycoses 53(3): 262-264, 2006.
4. Lin X and Heitman J: The biology of the Crypto-coccus neoformans species complex. Annu Rev Microbiol 60: 69-105, 2006.
5. Kwon-Chung KL, Boekhout T, Fell JW, and Diaz M: Proposal to conserve the name Cryptococcus gattii against C. hondurianus and C. bacillisporus Basidiomycota, Hymenomycetes, Tremenomy-cetidae. Taxon 51: 804-806, 2002.
6. Sriburee P, Khayhan S, Khamwan C, Panjaisee S, and Tharavichitkul P: Serotype and PCR-fingerprints of clinical and environmental isolates of Cryptococcus neoformans in Chiang Mai, Thailand. Mycopathologia 158(1): 25-31, 2004.
7. Morera-Lopez Y, Torres-Rodriguez JM, Jimenez-Cabello T, Baro-Tomas T, Alia-Aponte C, and Lazera MS: DNA fingerprinting pattern and susceptibility to antifungal drugs in Cryptococcus neoformans variety grubii isolates from Barcelona city and rural environmental samples. Myco-pathologia 160(1): 9-14, 2005.
8. Perez C, Dolande M, Moya M, Rosello A, de Capriles CR, Landaeta M E, and Mata-Essayag S: Cryptococcus neoformans, Cryptococcus gattii: serotypes in Venezuela. Mycopathologia 166(3): 149-153, 2008.
9. Nishikawa MM, Lazera MS, Barbosa GG, Trilles L, Balassiano BR, Macedo RC, Bezerra CC, Perez MA, Cardarelli P, and Wanke B: Serotyping of 467 Cryptococcus neoformans isolates from clinical and environmental sources in Brazil: analysis of host and regional patterns. J Clin Microbiol 41(1): 73-77, 2003.
10. Kronstad JW, Attarian R, Cadieux B, Choi J, D'Souza CA, Griffiths E J, Geddes J M, Hu G, Jung WH, Kretschmer M, Saikia S, and Wang J: Expanding fungal pathogenesis: Cryptococcus breaks out of the opportunistic box. Nat Rev Microbiol 9(3): 193-203, 2011.
11. Kielstein P, Hotzel H, Schmalreck A, Khaschabi D, and Glawischnig W: Occurrence of Cryptococcus spp. in excreta of pigeons and pet birds. Mycoses 43(1-2): 7-15, 2000.
12. NCCLs, Reference Method for Broth Dilution Antifungal Susceptibility Testing for Yeasts: Approved Standard M27-A2. NCCLs, ed. n. ed. Vol. 2nd ed. 2002: Wayne, PA.
13. Lopez-Jodra O, Torres-Rodriguez JM, Mendez-Vasquez R, Ribas-Forcadell E, Morera-Lopez Y, Baro-Tomas T, and Alia-Aponte C: In vitro susceptibility of Cryptococcus neoformans isolates to five antifungal drugs using a colorimetric system and the reference microbroth method. J Antimic-rob Chemother 45(5): 645-649, 2000.
14. Arechavala AI, Ochiuzzi ME, Borgnia MD, and Santiso GM: Fluconazole and amphotericin B susceptibility testing of Cryptococcus neoformans: results of minimal inhibitory concentrations against 265 isolates from HIV-positive patients before and after two or more months of antifungal therapy. Rev Iberoam Micol 26(3): 194-197, 2009.
15. Soogarun S, Wiwanitkit V, Palasuwan A, Pradniwat P, Suwansaksri J, Lertlum T, and Maungkote T: Detection of Cryptococcus neoformans in bird excreta. Southeast Asian J Trop Med Public Health 37(4): 768-770, 2006.
16. Liaw S J, Wu H C, and Hsueh P R: Microbiological characteristics of clinical isolates of Cryptococcus neoformans in Taiwan: serotypes, mating types, molecular types, virulence factors, and antifungal susceptibility. Clin Microbiol Infect 16(6): 696-703, 2010.
17. Day JN, Hoang TN, Duong AV, Hong CT, Diep PT, Campbell JI, Sieu TP, Hien TT, Bui T, Boni MF, Lalloo DG, Carter D, Baker S, and Farrar JJ: Most cases of cryptococcal meningitis in HIV-uninfected patients in Vietnam are due to a distinct amplified fragment length polymorphism-defined cluster of Cryptococcus neoformans var. grubii VN1. J Clin Microbiol 49(2): 658-664, 2011.
18. Archibald L K, Tuohy M J, Wilson D A, Nwanyanwu O, Kazembe P N, Tansuphasawadikul S, Eampokalap B, Chaovavanich A, Reller L B, Jarvis W R, Hall G S, and Procop G W: Antifungal susceptibilities of Cryptococcus neoformans. Emerg Infect Dis 10(1): 143-145, 2004.
19. Poonwan N, Mikami Y, Poosuwan S, Boon-Long J, Mekha N, Kusum M, Yazawa K, Tanaka R, Nishimura K, and Konyama K: Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents. Eur J Epidemiol 13(3): 335-340, 1997.
20. Sar B, Monchy D, Vann M, Keo C, Sarthou J L, and Buisson Y: Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. J Antimic-rob Chemother 54(2): 563-565, 2004.
21. Tan AL and Chan KS: In vitro activities of antifungal drugs against yeasts isolated from blood cultures and moulds isolated from various clinically significant sites in Singapore. Ann Acad Med Singapore 37(10): 841-846, 2008.
22. Pfaller MA, Zhang J, Messer SA, Brandt ME, Hajjeh RA, Jessup CJ, Tumberland M, Mbidde EK, and Ghannoum MA: In vitro activities of voricona-zole, fluconazole, and itraconazole against 566 clinical isolates of Cryptococcus neoformans from the United States and Africa. Antimicrob Agents Chemother 43(1): 169-171, 1999.
23. Tay ST, Rohani MY, Hoo TS, and Hamimah H: Epidemiology of cryptococcosis in Malaysia. Mycoses 53(6): 509-514, 2010.